Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.
Phase 1/2 Unknown
184 enrolled
UPSTREAM
Phase 2 Unknown
340 enrolled
RESOLUTE
Phase NA Unknown
75 enrolled
ACRIN6690
Phase NA Unknown
440 enrolled
ALT GIST
Phase 2 Unknown
78 enrolled
InterAACT
Phase 2 Unknown
91 enrolled
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
Phase 2 Unknown
251 enrolled
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Phase 2 Unknown
165 enrolled 15 charts
FB-12
Phase 2 Unknown
64 enrolled
"InDACtion" vs "3+7" Induction in AML
Phase 3 Unknown
606 enrolled
Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma
Phase 2 Unknown
50 enrolled
NWTTPS
Phase 1 Unknown
30 enrolled
Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
Phase 2 Unknown
64 enrolled
Vaccination for Children of H&O and Their Parents
Phase NA Unknown
300 enrolled
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
Phase 1 Unknown
33 enrolled
OMNI-Can
Phase 2 Unknown
200,000 enrolled
AF CRT +/- Nimorazole in HNSCC
Phase 3 Unknown
640 enrolled
The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission
Phase NA Unknown
75 enrolled
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Phase 3 Unknown
1,871 enrolled
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Phase 1 Unknown
30 enrolled
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
Phase 2 Unknown
35 enrolled
Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study
Phase 4 Unknown
48 enrolled
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Phase 2 Unknown
63 enrolled 16 charts
INTEGRATEIIa
Phase 3 Unknown
250 enrolled
LessStoReS
Phase NA Unknown
140 enrolled
CY25
Phase 3 Unknown
100 enrolled
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Phase 2 Unknown
57 enrolled 11 charts
Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors
Phase NA Unknown
120 enrolled
Validation of VI-RADS for the Detection of Detrusor Muscle Invasion
Phase NA Unknown
60 enrolled
MASTERPLAN
Phase 2 Unknown
120 enrolled
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Phase 3 Unknown
813 enrolled 14 charts
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
Phase 3 Unknown
1,157 enrolled 15 charts
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
Phase 3 Unknown
637 enrolled 18 charts
Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients
Phase NA Unknown
90 enrolled
DAHANCA30
Phase 3 Unknown
1,252 enrolled
H10
Phase 3 Unknown
1,952 enrolled
DAHANCA 35
Phase NA Unknown
600 enrolled
ACRIN6685
Phase NA Unknown
292 enrolled
DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC
Phase 2 Unknown
60 enrolled
ReAL
Phase NA Unknown
140 enrolled
READIT
Phase 2 Unknown
100 enrolled
DAHANCA 37. Re-irradiation With Proton Radiotherapy
Phase NA Unknown
20 enrolled
A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs
Phase 1/2 Unknown
40 enrolled
MARS
Phase NA Unknown
162 enrolled
VOCs vs FIT for Colorectal Cancer Screening
Phase NA Unknown
150 enrolled
LungTech
Phase 2 Unknown
39 enrolled
Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
Phase 2 Unknown
67 enrolled 9 charts
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
Phase 3 Unknown
601 enrolled 13 charts
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Phase NA Unknown
485 enrolled
Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer
Phase 1 Unknown
45 enrolled